FR2132601A1 - Anti-alcoholic compsns contng calcium 5-buty - Google Patents

Anti-alcoholic compsns contng calcium 5-buty

Info

Publication number
FR2132601A1
FR2132601A1 FR7113211A FR7113211A FR2132601A1 FR 2132601 A1 FR2132601 A1 FR 2132601A1 FR 7113211 A FR7113211 A FR 7113211A FR 7113211 A FR7113211 A FR 7113211A FR 2132601 A1 FR2132601 A1 FR 2132601A1
Authority
FR
France
Prior art keywords
calcium
alcoholic
contng
compsns
buty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7113211A
Other languages
French (fr)
Other versions
FR2132601B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to FR7113211A priority Critical patent/FR2132601A1/en
Publication of FR2132601A1 publication Critical patent/FR2132601A1/en
Application granted granted Critical
Publication of FR2132601B1 publication Critical patent/FR2132601B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Anti-alcoholic compsn. comprise a carrier and, as active ingredient, calcium 5-butylpicolinate (I) or calcium 5-pentyl-picolinate (II), in an amount of 50-200 mg per unit does. (I) and (II) inhibit dopamine-beta-hydroxylase, and are pref. administered orally at the rate of 200-800 mg/day in three or four unit doses. They are non-irritant to the stomach and non-toxic to patients suffering from hypertension.
FR7113211A 1971-04-07 1971-04-07 Anti-alcoholic compsns contng calcium 5-buty Granted FR2132601A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7113211A FR2132601A1 (en) 1971-04-07 1971-04-07 Anti-alcoholic compsns contng calcium 5-buty

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7113211A FR2132601A1 (en) 1971-04-07 1971-04-07 Anti-alcoholic compsns contng calcium 5-buty

Publications (2)

Publication Number Publication Date
FR2132601A1 true FR2132601A1 (en) 1972-11-24
FR2132601B1 FR2132601B1 (en) 1974-08-23

Family

ID=9075271

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7113211A Granted FR2132601A1 (en) 1971-04-07 1971-04-07 Anti-alcoholic compsns contng calcium 5-buty

Country Status (1)

Country Link
FR (1) FR2132601A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2030389A1 (en) * 1969-02-10 1970-11-13 Zaidan Hojin Biseibutsu

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2030389A1 (en) * 1969-02-10 1970-11-13 Zaidan Hojin Biseibutsu

Also Published As

Publication number Publication date
FR2132601B1 (en) 1974-08-23

Similar Documents

Publication Publication Date Title
IE812232L (en) Composition
IE37378B1 (en) Taste-improving formulations of oral penicillins
IE42950L (en) X-ray contrast preparations
KR890003391A (en) Calcium supplements
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
NL7104752A (en) Anti-alcoholic compsns contng calcium 5-buty
FR2132601A1 (en) Anti-alcoholic compsns contng calcium 5-buty
BE765809A (en) Anti-alcoholic compsns contng calcium 5-buty
GB1118606A (en) Compositions for the treatment of haemorrhoids
Hall et al. ADVANCED NEOPLASTIC DISEASE—Treatment with 5-Fluorouracil and Irradiation
FR2081364A1 (en) Compsn for oral calcitherapy
EP0093497A3 (en) Anthelmintic treatment
US4216207A (en) Method and composition for treatment of gastro-duodenal ulcers
IE36780B1 (en) New pharmaceutical preparations
GB1437138A (en) Method of increasing sexual potency
REIMANN et al. Chloramphenicol in Paratyphoid A: Observations with a Note on the Clinical Aspects of the Disease
GB1424611A (en) Pharmaceutical compositions
GB1375806A (en)
DAVIS Thiabendazole in Pinworm Infestations: II. Comparison of Single and Intermittent Therapy, Long-Term Follow-Up, and Evaluation of New Dosage Form
FR2085730A1 (en) Salicylamide salts for oral administration
FR2105044A1 (en) Ortho-amino benzo phenone or its oxime - as anti-rheumatic agent
GB1422745A (en) Pharmaceutical compositions containing 4-hydroxy- 1,23-benzotriazine and methods of using same
Greenwood, Frank & Samuel Benign ulcers on the greater curvature of the stomach
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth
Laurence Basic NHS Costs Para-seltzer tablets (100)€ 1.98 Paracetamol tablets BP (100) 33p Panodol effervescent tablets (24) 23P

Legal Events

Date Code Title Description
ST Notification of lapse